Eric David, MD, JD, Chief Strategy Officer, Organovo

Dr. David has more than 15 years of experience in biomedical research and product development. He played a critical role in the commercial translation of 3D bioprinting as a founder and early director of Organovo, Inc. Dr. David was most recently associate partner at the consultancy McKinsey & Company, where he served private equity, pharmaceutical, biotech, diagnostic, and medical device clients to support pipeline and R&D strategy, as well as market entry strategy. Prior to his time at McKinsey, Dr. David served as a freelance consultant to the Department of Health and Human Services in the use of genomic technologies for early detection of pathogens for public health preparedness. He completed his residency in Internal Medicine at New York Presbyterian Hospital, where he served as Assistant Chief Resident and received the Dick Bowman Award for scientific endeavor and dedication to patient care. He was also Assistant Professor at The Rogosin Institute, adjunct faculty at The Rockefeller University, and a lecturer in Medicine at Weill Cornell Medical College. He received his M.D. from Columbia University College of Physicians and Surgeons, his J.D. from Columbia University School of Law, and a B.A. in Physics and Fine Arts from Amherst College. He is board certified in Internal Medicine and admitted to the Bar in New York State.